A prize-collecting Steiner tree application for signature selection to stratify diffuse large B-cell lymphoma subtypes

Abstract

Background:With the explosion of high-throughput data available in biology, the bottleneck is shifted to effective data interpretation. By taking advantage of the available data, it is possible to identify the biomarkers and signatures to distinguish subtypes of a specific cancer in the context of clinical trials. This requires sophisticated methods to retrieve the information out of the data, and various algorithms have been recently devised.Results:Here, we applied the prize-collecting Steiner tree (PCST) approach to obtain a gene expression signature for the classification of diffuse large B-cell lymphoma (DLBCL). The PCST is a network-based approach to capture new insights about genomic data by incorporating an interaction network landscape. Moreover, we adopted the ElasticNet incorporating PCA as a classification method. We used seven public gene expression profiling datasets (three for training, and four for testing) available in the literature, and obtained 10 genes as signature. We tested these genes by employing ElasticNet, and compared the performance with the DAC algorithm as current golden standard. The performance of the PCST signature with ElasticNet outperformed the DAC in distinguishing the subtypes. In addition, the gene expression signature was able to accurately stratify DLBCL patients on survival data.Conclusions:We developed a network-based optimization technique that performs unbiased signature selection by integrating genomic data with biological networks. Our classifier trained with the obtained signature outperformed the state-of-the-art method in subtype distinction and survival data stratification in DLBCL. The proposed method is a general approach that can be applied on other classification problems.